TASER International to Showcase New Innovative Products and Concepts at the International Association of Chiefs of Police Conference in San Diego


SCOTTSDALE, Ariz., Nov. 7, 2008 (GLOBE NEWSWIRE) -- TASER(r) International, Inc. (Nasdaq:TASR), the market leader in advanced electronic control devices, will showcase several new innovative products and concepts at the International Association of Chiefs of Police (IACP) annual conference in San Diego, November 9 - 11.

TASER International will demonstrate its new products and concepts in Booth 4305 in the San Diego Convention Center during the IACP conference.

Products and concepts to be showcased include:

TASER(r) AXON(tm) -- The TASER AXON is an on officer tactical computing platform that initially combines audio and video recording capabilities which integrates with existing communications platforms. The technology allows officers to record audio and video of critical incidents from the visual perspective of the officer. The intent of the AXON is to be an information multiplier for the officer providing an unbiased view of situations that the officer chooses to record.

TASER(r) Controlled Digital Power Magazine CDPM(tm) -- The CDPM is an added on accessory for the TASER(r) X26E(tm) device. The CDPM has the same functions as the DPM(tm) (Digital Power Magazine); however, the CDPM features a safety lanyard designed to secure the device to an officer. If a prisoner or suspect attempts to take the TASER X26E device away and breaks the lanyard connection, the system is designed to instantly deactivate the X26E. Orders are now being taken for the CDPM with shipments expected by the end of this year.

TASER(r) Shockwave(tm) -- The Shockwave is the first generation of the new TASER Remote Area Denial (TRAD) technology. With the push of a button at a stand-off distance of up to 100 meters, the Shockwave unit deploys multiple standard TASER(r) cartridges that are oriented across an area arc. Full area coverage is provided to instantaneously incapacitate multiple personnel within that region.

TASER(r) XREP(tm), also known as the eXtended Range Electronic Projectile -- is a self-contained wireless projectile that deploys from a 12-gauge shotgun. It delivers the same Neuro Muscular Incapacitation as our handheld TASER X26, but can be delivered to a distance of 75 feet (22.5 meters).

Further information on all TASER products can be found at www.TASER.com.

"The AXON is the next great innovative step in law enforcement technology," stated Rick Smith, CEO and Founder of TASER International. "It will help provide revolutionary digital evidence collection, storage and retrieval for law enforcement. Used alongside other TASER devices, law enforcement officers will now be able to protect life and protect truth."

"We are excited to be taking orders for our new TASER CDPM system that enables officer's additional protection if their TASER device is ever compromised," added Smith. "Being able to showcase a variety of products that we have been working on for the past year to a distinguished audience of law enforcement personal is rewarding in itself. We will continue to enhance and engineer products available for officer use in the field that will help them protect lives."

About TASER International, Inc.

TASER International's products protect life. TASER provides advanced Electronic Control Devices (ECDs) for use in the law enforcement, medical, military, corrections, professional security, and personal protection markets. TASER devices use proprietary technology to incapacitate dangerous, combative, or high-risk subjects who pose a risk to law enforcement officers, innocent citizens, or themselves in a manner that is generally recognized as a safer alternative to other uses of force. For more information, please call TASER International at (800) 978-2737 or visit our website at www.TASER.com.

The TASER International logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2931

Note to Investors

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements, without limitation, regarding our expectations, beliefs, intentions or strategies regarding the future. We intend that such forward-looking statements be subject to the safe-harbor provided by the Private Securities Litigation Reform Act of 1995. The forward-looking information is based upon current information and expectations regarding TASER International. These estimates and statements speak only as of the date on which they are made, are not guarantees of future performance, and involve certain risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results could materially differ from what is expressed, implied, or forecasted in such forward-looking statements.

TASER International assumes no obligation to update the information contained in this press release. These statements are qualified by important factors that could cause our actual results to differ materially from those reflected by the forward-looking statements. Such factors include but are not limited to: (1) market acceptance of our products; (2) our ability to establish and expand direct and indirect distribution channels; (3) our ability to attract and retain the endorsement of key opinion-leaders in the law enforcement community; (4) the level of product technology and price competition for our products; (5) the degree and rate of growth of the markets in which we compete and the accompanying demand for our products; (6) risks associated with rapid technological change and new product introductions; (7) competition; (8) litigation including lawsuits resulting from alleged product related injuries and death; (9) media publicity concerning allegations of deaths and injuries occurring after use of the TASER device and the negative effect this publicity could have on our sales; (10) TASER device tests and reports; (11) product quality; (12) implementation of manufacturing automation; (13) potential fluctuations in our quarterly operating results; (14) financial and budgetary constraints of prospects and customers; (15) order delays; (16) dependence upon sole and limited source suppliers; (17) negative reports concerning the TASER device; (18) fluctuations in component pricing; (19) government regulations and inquiries; (20) dependence upon key employees and our ability to retain employees; (21) execution and implementation risks of new technology; (22) ramping manufacturing production to meet demand; (23) medical and safety studies; (24) field test results; and (25) other factors detailed in our filings with the Securities and Exchange Commission, including, without limitation, those factors detailed in the Company's Annual Report on Form 10-K and its Form 10-Qs.

The statements made herein are independent statements of TASER International. The inclusion of any third parties does not represent an endorsement of any TASER International products or services by any such third parties.



            

Coordonnées